PROVECTUS BIOPHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Knoxville, TN
SEC filing record 1 source field available
Fiscal year end
31 December
PROVECTUS BIOPHARMACEUTICALS, INC. has filed 1,070 SEC EDGAR filings since 31 Mar 2000

SEC filing history

Showing 301-325 of 796 matching filings.

Per page
25
Current page
13
8-K File 001-36457

8-K filing

Filing date
26 Feb 2018
Reporting date
23 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K filing

Filing date
22 Feb 2018
Reporting date
22 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K filing

Filing date
30 Jan 2018
Reporting date
25 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Dec 2017
Reporting date
14 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K filing

Filing date
12 Dec 2017
Reporting date
12 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K filing

Filing date
30 Nov 2017
Reporting date
30 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36457

10-Q filing

Filing date
08 Nov 2017
Reporting date
30 Sep 2017
Next action
Verify source filing
8-K File 001-36457

8-K filing

Filing date
18 Oct 2017
Reporting date
18 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K filing

Filing date
21 Sep 2017
Reporting date
21 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36457

10-Q filing

Filing date
09 Aug 2017
Reporting date
30 Jun 2017
Next action
Verify source filing
8-K File 001-36457

8-K filing

Filing date
01 Aug 2017
Reporting date
25 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
01 Jun 2017
Reporting date
30 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
27 Apr 2017
Reporting date
21 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36457

DEF 14A

Filing date
27 Apr 2017
Reporting date
30 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DFAN14A File 001-36457

DFAN14A

Filing date
21 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 001-36457

25-NSE filing

Filing date
21 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 001-36457

25-NSE filing

Filing date
21 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRER14A File 001-36457

PRER14A

Filing date
20 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
20 Apr 2017
Reporting date
19 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DFAN14A File 001-36457

DFAN14A

Filing date
19 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
18 Apr 2017
Reporting date
12 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-36457

PRE 14A

Filing date
17 Apr 2017
Reporting date
30 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-32172

SC 13D/A

Filing date
17 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Apr 2017
Reporting date
03 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .